Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels-Reference-Cited by-同舟云学术

Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels

Published:2011-09 Issue:1 Volume:218 Page:226-232
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Nakatani Kazuhiro,Sugimoto Taizo,Masuda Daisaku,Okano Rieko,Oya Tomoko,Monden Yasumasa,Yamashita Taiji,Kawase Ryota,Nakaoka Hajime,Inagaki Miwako,Yuasa-Kawase Miyako,Tsubakio-Yamamoto Kazumi,Ohama Tohru,Nishida Makoto,Ishigami Masato,Komuro Issei,Yamashita Shizuya

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study;Kannel;Ann Intern Med,1971

2. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

3. Serum triglycerides in coronary artery disease;Albrink;AMA Arch Intern Med,1959

4. Plasma triglyceride and coronary heart disease;Austin;Arterioscler Thromb,1991

5. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease;Eberly;Arch Intern Med,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Analysis of Human Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation;Journal of Atherosclerosis and Thrombosis;2024

2. Subclinical atherosclerosis burden in non-diabetic hypertensives treated in primary care center: the IMTABI study;BMC Primary Care;2023-02-09

3. The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study);Frontiers in Cardiovascular Medicine;2023-01-25

4. Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan;BMJ Open;2022-11

5. Evaluation of Event Risks of Cerebro- and Cardiovascular Diseases by Focusing on the Profile of Atherogenic Lipoproteins Developing Atherosclerotic Plaque, not the Value of Lipids;Health Evaluation and Promotion;2020-11-10